... (for instance, Commonwealth Fusion Systems secured about $1 billion). In biotechnology and medtech, deals are also growing larger: AI-enabled platforms for drug discovery, new genetic solutions, and other medical startups are accumulating substantial capital from funds. For instance, American startup Centivax raised $45 million for developing a universal flu vaccine. The cybersecurity segment remains one of the market’s drivers (as exemplified by the Cato Networks deal mentioned above). Crypto and Web3 startups are beginning to revive after a deep slump— ...

... invest in AI leaders, pouring colossal sums into the most promising projects. Almost every week, new mega funding rounds are announced, reaffirming AI's status as the main "magnet" for venture capital. For instance, Elon Musk's startup xAI raised about $10 billion (half from equity capital, half from debt financing) and gained enormous resources for developing its AI platform. Insider estimates suggest xAI's value now exceeds $100 billion, making it one of the most valuable private companies in the world. Industry leader OpenAI ...

... first half of the year, unprecedented mega rounds took place: an investment consortium led by SoftBank invested approximately $40 billion in AI developer OpenAI — the largest private funding in the history of the tech industry. Elon Musk's startup xAI raised a total of about $10 billion (including both venture and debt capital), achieving a valuation of over $100 billion and entering the ranks of the world's most valuable private companies. Meta Corporation invested $14 billion in the AI data platform Scale AI, aiming to accelerate its own developments in artificial ...

... SPACs is starting to grow in Russia despite the existing challenges. SPAC (Special Purpose Acquisition Company) has emerged as a popular mechanism for going public, particularly in the United States, where many companies are leveraging this tool to raise capital and conduct public offerings. SPAC facilitates a quicker market entry, reduces costs, and minimizes risks compared to traditional IPOs. This article will explore the key features of SPAC, its advantages and disadvantages, examples of successful ...

... billion for further developments. Biotech and Medtech: Significant rounds are taking place in biotechnology and medical startups. Platforms developing drugs using AI, genetic technologies, and other medtech projects are again attracting substantial capital. For example, biomedical company Altos Labs continues to raise hundreds of millions for research in extending human life, while the Greek project Centivax secured over €130 million for creating a next-generation universal vaccine. Defense Technologies: Investments in startups related to defense and security ...